Gilead Sciences Inc
Change company Symbol lookup
Select an option...
GILD Gilead Sciences Inc
CWBR CohBar Inc
TSLA Tesla Inc
WEC WEC Energy Group Inc
PFE Pfizer Inc
T AT&T Inc
BFC Bank First Corp
RIGMF Ridgestone Mining Inc
BAC Bank of America Corp
WFC Wells Fargo & Co

Health Care : Biotechnology | Large Cap Value
Company profile

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Closing Price
Day's Change
0.29 (0.38%)
B/A Size
Day's High
Day's Low

10-day average volume:

UPDATE: A fresh stock-market crisis will emerge from the 'breathtaking disconnect between Main Street and Wall Street,' fund manager warns

1:49 pm ET June 13, 2020 (MarketWatch)

By Shawn Langlois, MarketWatch

Long-suffering stock market bears have to be eating up Thursday's nasty action, with the Fed's grim economic outlook and troubling coronavirus headlines sending the Dowdown more than 1,800 points on its way to one of its worst showings in a long time.

Leading up to the steep drop, John Hussman of Hussman Investment Trust , who hasn't shied away from addressing his misfires in recent years (, once again offered up his gloomy take on the market's prospects in his latest note to clients.

"In the face of a breathtaking disconnect between Main Street and Wall Street, largely based on overconfidence in free money, my sense is that there remains a crisis ahead that will emerge 'gradually, then suddenly,'" he wrote, referring to Ernest Hemingway's famous quote from "The Sun Also Rises" about going bankrupt, "gradually, then suddenly."

Hussman singled out six widely held stocks, in particular, he believes are vulnerable when the mood turns to risk-off: Facebook(FB) , Apple(AAPL) , Amazon(AMZN) , Netflix(NFLX) , Google(GOOGL) and Microsoft(MSFT) .

Hussman used that chart to show how the two-year revenue growth of some of those massive companies has "slowed remarkably" compared with the "spectacularly high" rates of prior years.

"All of these companies are headed toward growth rates that are likely to converge toward single-digit rates similar to the growth rate of the overall economy," Hussman predicted. "That's not how investors are pricing these large-cap glamour stocks."

This is reminiscent of the "Nifty Fifty" stock boom of the 1970's and the high-flyers of the tech bubble in 2000, he explained, adding that every indication is that the same process of unwinding is underway today which could have sweeping implications for the health of the market.

"The wide dispersion between richly-valued, mega-cap components of the S&P 500 and the broader market is likely to create an enormous headwind for passive index investors over the coming decade, but will simultaneously create enormous opportunities for investors with the flexibility to pursue broad, value-conscious stock selection," Hussman said.

In Thursday's selloff, with the S&P 500closing off almost 6%, all the "glamour" names were in the red, led by Microsoft's 5.4% drop.

-Shawn Langlois; 415-439-6400;

(END) Dow Jones Newswires

June 13, 2020 13:49 ET (17:49 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.